Age, Biography and Wiki
Diana Zuckerman was born on 16 June, 1950 in United States, is an American health policy analyst. Discover Diana Zuckerman's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 73 years old?
Popular As |
N/A |
Occupation |
N/A |
Age |
73 years old |
Zodiac Sign |
Gemini |
Born |
16 June 1950 |
Birthday |
16 June |
Birthplace |
N/A |
Nationality |
United States
|
We recommend you to check the complete list of Famous People born on 16 June.
He is a member of famous with the age 73 years old group.
Diana Zuckerman Height, Weight & Measurements
At 73 years old, Diana Zuckerman height not available right now. We will update Diana Zuckerman's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
Physical Status |
Height |
Not Available |
Weight |
Not Available |
Body Measurements |
Not Available |
Eye Color |
Not Available |
Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
Family |
Parents |
Not Available |
Wife |
Not Available |
Sibling |
Not Available |
Children |
Not Available |
Diana Zuckerman Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Diana Zuckerman worth at the age of 73 years old? Diana Zuckerman’s income source is mostly from being a successful . He is from United States. We have estimated Diana Zuckerman's net worth, money, salary, income, and assets.
Net Worth in 2024 |
$1 Million - $5 Million |
Salary in 2024 |
Under Review |
Net Worth in 2023 |
Pending |
Salary in 2023 |
Under Review |
House |
Not Available |
Cars |
Not Available |
Source of Income |
|
Diana Zuckerman Social Network
Timeline
Diana M. Zuckerman (born 16 June 1950 ) is an American health policy analyst who focuses on the implications of policies for public health and patients' health.
She specializes in national health policy, particularly in women's health and the safety and effectiveness of medical products.
She is the President of the National Center for Health Research (formerly National Research Center for Women & Families) and the Cancer Prevention and Treatment Fund.
Zuckerman earned her B.A. in psychology from Smith College and then obtained a Ph.D. in psychology from the Ohio State University in 1977.
At Yale Medical School she was a post-doctoral fellow in epidemiology and public health from 1979 to 1980.
She was on the faculty at Vassar College and Yale University, and directed a longitudinal study of college students as director of the Seven College Study at Harvard University, publishing books and articles on the impact of media on children, the impact of religion on the health of the elderly, and how women's life experiences influence their mental and physical health.
She left academia in 1983 when she was selected as a Fellow in the American Association for the Advancement of Science Congressional Science Fellowship program.
From 1985 to 1993 she worked at the U.S. Congress in a House subcommittee where she was responsible for a dozen Congressional oversight investigations on health and social policy, including political manipulation of government grants to prevent child abuse, lack of safeguards for infertility treatments, financial conflicts of interest among National Institutes of Health (NIH) grant recipients, and the lack of safety studies on breast implants.
Information from the hearings received widespread public health, government, and media attention, resulting in several policy and regulatory changes, including the U.S. Food and Drug Administration (FDA) requiring implant manufacturers to submit safety studies for the first time.
In 1993, Zuckerman joined the staff of the Senate Veterans Affairs Committee and began an investigation that resulted in the first Congressional hearings focused on the possible causes of Gulf War syndrome.
In 1995 she was a senior policy advisor in the Clinton Administration.
From 1996, she undertook leading roles in non-profit organizations, including, from 1999, presidency of the National Research Center for Women & Families (renamed the National Center for Health Research in 2014) and The Cancer Prevention and Treatment Fund.
Her work focuses on improving the quality of medical products and healthcare in the United States.
She has been highly critical of scientific and medical research paid for by companies, who then use this to promote their products, as well as the lack of media coverage on independently funded research that challenges industry-funded research.
In February 2011, Zuckerman and colleagues Paul Brown and Dr. Steven Nissen published a study in the peer-reviewed journal Archives of Internal Medicine, which evaluated the FDA's recalls of devices that the agency considered potentially deadly or otherwise very high risk.
Based on FDA data, the authors determined that most of the devices that were high-risk recalls had never been studied in clinical trials prior to FDA approval, and that the FDA needed to use more stringent criteria for implanted medical devices and those used to diagnose serious illnesses, and an editorial in the same issue agreed.
In April 2011, Zuckerman presented the results of the study at a hearing by the U.S. Senate Special Committee on Aging.
Zuckerman is the author of five books, several book chapters, and dozens of articles in medical and academic journals, and in newspapers across the country.
Her policy work has resulted in news coverage on all the major TV networks, including ABC, CBS, NBC, CNN, Fox News, public television, 60 Minutes, 20/20, National Public Radio, and in major U.S. print media such as The New York Times, The Washington Post, The Washington Times, Los Angeles Times, The Boston Globe, USA Today, Detroit Free Press, New York Daily News, Newsweek, Time, U.S. News & World Report, Family Circle, The New Yorker, Glamour, Self, as well as many other newspapers, magazines, and radio programs.
Zuckerman frequently writes articles regarding medical drugs and devices, as well as public health policy.
Recent articles published in peer-reviewed journals include: